CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-15). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2650 · Search date 2026-08-15 · Methodology v0.7

Occupational therapist home-hazard removal,
does it really help with Lower hazard of a first fall over 12 months in high-risk community-dwelling older adults?

30-Second Summary
D
Evidence Grade D · 34 · Safety acceptable
Repeat-fall burden declined, but the hazard of a first fall did not
No major harm signal was reported for professionally tailored hazard removal. Poorly installed fixtures or inappropriate changes can create new trip or fall hazards, so professional review is advisable.
What the
research shows
The grade is D with 34 points. In a 310-person RCT, at least one fall occurred in 67 participants (50%) with HARP versus 74 (53%) with usual care, and first-fall HR was 0.90 (95% CI 0.66 to 1.27), P=.59. Total fall count fell as a secondary outcome, but the prespecified primary hazard of a first fall did not significantly decrease.
What the
ads claim
Grab bars, lighting, and removal of slip or trip hazards are sensible safety measures, but home modification alone is not guaranteed to prevent a first fall in every high-risk older adult. It should be distinguished from multifactorial programs that also address exercise, medication, and vision.
*

Useful facts when choosing a product

  • HARP included occupational-therapist assessment, a tailored hazard-removal plan, low-cost modification tools, and self-management education.
  • Randomization was 155 per group; the primary analysis included 134 versus 140, while secondary-outcome retention was 127 (82%) versus 126 (81%).
  • First fall and total fall rate are different outcomes.
Gap Measurement · Verdict 2650 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2021 HARP RCT by Stark S, Keglovits M, Somerville E, Hu YL, Barker A, Sykora D, and Yan Y randomized 310 high-risk older adults, 155 per group. The primary first-fall analysis included 134 intervention and 140 control participants, 274 total; first falls were 67 versus 74, HR 0.90 (0.66 to 1.27). Primary-outcome attrition was 36/310, about 11.6%. Retention of 127 intervention participants (82%) and 126 controls (81%) applied to secondary outcomes. The registry and protocol designated first-fall hazard as primary, matching the paper. Outcome assessors were masked, but participants were not and falls were self-reported in diaries. HUD grant MOHHU0024-14 funded the work.

02

Why this is classified as D (34)

The publicly funded RCT had a null real-event primary outcome, retained substantial possible benefit, and had primary-outcome attrition of 36/310 (about 11.6%), with unmasked participants and self-reported fall diaries; the grade is D with 34 points.

Counterpoint. The secondary reduction in total falls suggests possible benefit for repeated-fall burden, so the program should not be read as wholly worthless.

Rejudgment record. Cross-check applied — Cross-checked 310 randomized, follow-up counts, registered first-fall primary outcome, HR and interval, secondary fall rate, and public funding against the JAMA Network Open paper, protocol, and NCT record

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower hazard of a first fall over 12 monthsDThe result was null, HR 0.90 (0.66 to 1.27).
Lower total fall rate over 12 monthsBThe secondary endpoint RR was 0.62 (0.40 to 0.95).

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Stark S, Keglovits M, Somerville E, Hu YL, Barker A, Sykora D, Yan Y. 2021 HARPAssessor-masked pragmatic randomized trial of occupational-therapist home-hazard removal versus usual care126US Department of Housing and Urban Development grant MOHHU0024-14Hazard of a first fall over 12 monthsAt least one fall in 67 (50%) versus 74 (53%); HR 0.90 (95% CI 0.66 to 1.27), P=.59Single publicly funded primary real-event trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-15).

Stark S, Keglovits M, Somerville E, Hu YL, Barker A, Sykora D, Yan Y. Home Hazard Removal to Reduce Falls Among Community-Dwelling Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(8):e2122044. PMID: 34463746. DOI: 10.1001/jamanetworkopen.2021.22044. NCT02392013.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-15 · Corrections: none

Cite this verdict

Occupational therapist home-hazard removal x prevention of a first fall Evidence Grade D card
[Chamgap] Occupational therapist home-hazard removal x prevention of a first fall — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/occupational-therapist-home-hazard-removal-first-fall/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.